GET A CUSTOMIZED SCOPE TO MATCH YOUR NEED ASK AN EXPERT – https://www.persistencemarketresearch.com/ask-an-expert/31735

According to Women’s Health initiative study, POP prevalence rate is 41% of women in age range of 50 to 59 years. It occurs due to child birth or labor and may weaken with age, but only 3% of women globally report symptoms. Surgical and non-surgical treatments are not a full measure to treat POP. Pelvic floor exercises to strengthen muscles like Kegel and medical devices such as Pessary are used to treat women non-surgically.

Growing prevalence of POP in aging female population and advancements in diagnosis of POP is expected to increase the global pelvic organ prolapse repair market. In addition, frequent need for treatment and technical advancements in pelvic organ prolapse repair treatments are expected to drive the future growth of the pelvic organ prolapse repair market.

High costs involved in surgeries and high reoccurrence rates owing to lack of effective treatment is expected to hamper growth of global pelvic organ prolapse repair market. Lack of scientific efficacy and safety and regulatory issues are expected to hinder the growth of global pelvic organ prolapse repair market.

Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com

Market Segmentation

Key Players

Some of the players operating in the Pelvic organ prolapse repair market are Cooper Medical Inc., ConTIPI Medical Ltd, MedGyn products, Inc., Personal Medical Corp, Integra Lifesciences Corporation, Panpac Medical Corp, Johnson & Johnson, Boston Scientific, Medtronic, MEDesign Ltd., and others.

GAIN COMPLETE ACCESS TO THE REPORT PRE-BOOK HERE – https://www.persistencemarketresearch.com/checkout/31735